Introduction {#Sec1}
============

Based on the Japanese gastric cancer treatment guidelines, curative treatment for gastric cancer consists of surgical resection with adequate lymph node dissection. An adequate resection margin of 2 cm is required with T1 tumors, 3 cm for T2 tumors with an expansive growth pattern, and 5 cm for those with infiltrative growth patterns. Additionally, D1 or D1+ lymphadenectomy is indicated for cT1N0 tumors, and D2 is indicated for cN+ or cT2--T4 tumors \[[@CR1]\]. Lymph node yield in gastric cancer surgery is strongly associated with survival and therefore considered a marker for quality of care \[[@CR2]--[@CR4]\]. Since Kitano et al. described the first laparoscopic distal gastrectomy in 1994, the minimally invasive technique has gained increased interest worldwide \[[@CR5]\].

Most studies regarding minimally invasive gastrectomy showed good outcomes in countries such as Japan and Korea where there is a relatively high incidence of early gastric cancer because of the screening programs for gastric cancer \[[@CR6], [@CR7]\]. There is no screening program for gastric cancer in Western countries and a higher incidence of advanced gastric cancer occurs; thus, the results from Asian studies might not be directly applicable for Western countries. Controversy exists whether postoperative outcomes, radicality, and lymph node yield are influenced by the surgeon's learning curve, resulting in a slow acceptance and implementation of minimally invasive gastrectomy in the Western world \[[@CR8]\].

To compare the outcomes of minimally invasive surgical techniques with open surgical techniques for gastric cancer, several meta-analyses have been conducted in recent years \[[@CR9], [@CR10]\].

However, those studies did not differentiate between outcomes in Eastern Asia and the Western world. The aim of this study is to compare the outcomes of the studies conducted in Asia with the studies conducted in the West.

Materials and methods {#Sec2}
=====================

Literature search {#Sec3}
-----------------

To identify all relevant publications, a systematic search was performed in the bibliographic databases PubMed, EMBASE.com, and The Cochrane Library (via Wiley) from inception to 24 January 2017. Search terms included controlled terms from MeSH in PubMed, EMtree in EMBASE.com, as well as free text terms. Free text terms were only used in The Cochrane library. Search terms expressing 'stomach neoplasms' were used in combination with search terms constituting 'open surgery' and 'laparoscopy.' The reference list of included articles was hand searched for relevant publications.

Selection criteria {#Sec4}
------------------

The search findings were independently evaluated for potential eligibility for this meta-analysis by two authors (J.S. and N.W.). The inclusion criteria were (1) the article had to compare minimally invasive gastrectomy with open gastrectomy; (2) only full text articles were included; case reports were not included; (3) the article had to be in English (no other language was accepted); and (4) only gastrectomy for gastric cancer was included. After this selection, another selection based on type of gastrectomy was made. In this systematic review only articles with total or total and subtotal gastrectomies combined were included.

Study characteristics {#Sec5}
---------------------

The Newcastle-Ottawa Quality Assessment Scale (NOS) for retrospective cohort studies and case--control studies was used to assess the quality of the studies. A maximum of nine points could be awarded: four points for selection criteria, two points for comparability, and three points for outcomes. Studies achieving six or more points would be classified as high quality and were used for further analysis. Quality of randomized controlled trials (RCT) was assessed using the Jadad scale for RCT. A maximum of five points could be awarded: two points for adequate randomization, two points for adequate blinding, and one point if all included patients were accounted for.

Definitions {#Sec6}
-----------

The following definitions were used for the recorded parameters. Regarding operative data: operation duration was defined in minutes (min) and blood loss in milliliters (ml). Hospital stay: time to first flatus and time to first oral intake were reported in days. Definitions of complications varied between different studies: there was no consensus in reporting type or grade of complication such as the Clavien--Dindo grading system for the classification of surgical complications. Therefore, only the frequency of postoperative complications was reported. In-hospital mortality was defined as mortality during hospital stay or within 30 days postoperatively. Proximal and distal resection margins were reported in centimeters.

Statistical analysis {#Sec7}
--------------------

The systematic review was performed in line with the recommendations from the PRISMA statement for reporting systematic reviews and meta-analyses \[[@CR11]\]. Review Manager version 5.3.5 (2014) was used for data analyses. Continuous variables were assessed using the weighted mean difference. Dichotomous variables were assessed using the odds ratio. To account for clinical heterogeneity, the random effects model based on DerSimonian and Laird's method was used \[[@CR12]\]. A *P* value \<0.05 was considered statistically significant.

A sub-analysis was made in Review Manager for studies conducted in Asian countries and studies conducted in Western countries. The analyses, performed using Review Manager, only compared the outcomes in the minimally invasive group with the outcomes in the open group. Therefore, calculation of the weighted means per outcome in the Western group and the Eastern group was conducted. Overall weighed means are displayed in Table [1](#Tab1){ref-type="table"}.Table 1Overall weighted mean outcomesWestEastMIGOGMIGOGAge67.5468.7460.7059.44BMI23.9724.3822.3522.69Blood loss149.64397.4883.52213.05Operative time243.02233.87218.81217.80First diet4.416.354.794.85First flatus2.905.753.933.96Hospital stay9.7411.2213.6614.85Complications (%)21.6930.8012.2315.79Mortality (%)3.275.810.330.24Lymph nodes22.9618.8831.2932.35*MIG* minimally invasive gastrectomy, *OG* open gastrectomy, *BMI* body mass index

Results {#Sec8}
=======

Study selection {#Sec9}
---------------

The initial literature search resulted in 2182 hits. After deleting duplicate articles, 1429 articles remained suitable for analysis. After selection on title and abstract, 181 articles remained that met the criteria. Sixty articles did not meet the criteria and were not suitable for analysis after reading the full text. Thus, 121 suitable articles were left. After assessing type of gastrectomy and the quality of the study, using the Newcastle Ottawa quality assessment scale for cohort studies and the Jadad scale for randomized controlled trials, a total of 20 studies were included, 19 retrospective studies and 1 randomized controlled trial (RCT) \[[@CR13]--[@CR32]\]. Twelve studies were conducted in Asian countries; 8 studies were conducted in Western countries. An overview of the selected articles and patient characteristics is depicted in Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}.Table 2Newcastle Ottawa Quality Assessment Scale and Jadad scoreReferencesRepresentatives of the exposed cohortSelection of the nonexposed cohortAscertainment of exposureDemonstration that outcome of interest was not present at start of studyComparability of cohorts (max. 2 points)Assessment of outcomeFollow-up long enough for outcome of interestAdequacy of follow-upTotalCianchi \[[@CR25]\]111121119Dulucq \[[@CR26]\]101121118Ecker \[[@CR27]\]111121007Guzman \[[@CR28]\]101111117Pugliese \[[@CR29]\]101111117Ramagem \[[@CR30]\]111111006Siani \[[@CR31]\]010121117Topal \[[@CR32]\]111111118An \[[@CR13]\]111121119Du \[[@CR14]\]011120117Jeong \[[@CR15]\]111111118Kawamura \[[@CR16]\]011121006Kim \[[@CR17]\]011120117Kim \[[@CR18]\]111121119Lin \[[@CR19]\]111111118Mochiki \[[@CR20]\]011110116Sakuramoto \[[@CR21]\]011110116Son \[[@CR22]\]011121118Usui \[[@CR23]\]001120116ReferencesRandomization\
mentionedRandomization appropriateBlinding mentionedBlinding appropriateAll patients accounted forTotalCui \[[@CR24]\]111115 Table 3Patient characteristicsReferencesStudy periodDesignCountrySample sizeMean ageSex M/FBMITumor stage (%)Lymph node dissectionMIGOGMIGOGMIGOGMIGOGIIIIIIIVCianchi \[[@CR25]\]06/2008 01/2012RetrospectiveItaly414124/1725/162818540D1+ α/β/D2Dulucq \[[@CR26]\]04/1995 03/2004RetrospectiveFrance81175 ± 867 ± 143/55/6D1+ βEcker \[[@CR27]\]01/1998 12/2011RetrospectiveUSA331230368.85 ± 12.1169.08 ± 13.01204/1271342/96114.837.147.40Guzman \[[@CR28]\]11/1999 01/2009RetrospectiveUSA3048706717/1331/1724.725.644.933.310.311.5D1/D2Pugliese \[[@CR29]\]06/2000 06/2005RetrospectiveItaly489985.46.38.30D1+/D2Ramagem \[[@CR30]\]08/2009 04/2013RetrospectiveBrazil476457.8 ± 10.5359.7 ± 11.6534/1343/2123.2 ± 4.3623.8 ± 4.0431.526.142.40D2Siani \[[@CR31]\]01/2003 10/2009Matched cohortItaly252565 ± 8.566 ± 7.815/1018/72020600Topal \[[@CR32]\]01/2003 12/2006RetrospectiveBelgium382266.3 ± 12.366.9 ± 14.623/1517/524.3 ± 2.823.4 ± 4.14023.326.710D2An \[[@CR13]\]2003--2007RetrospectiveKorea4216257.0 ± 11.656.6 ± 12.023/19108/54D1+ β/D2Du \[[@CR14]\]11/2005 05/2009RetrospectiveChina829460.4 ± 18.557.8 ± 17.254/2861/3322.3 ± 2.622.5 ± 2.45.138.156.80D2Cui \[[@CR24]\]10/2010 09/2012RCTChina12814260.1 ± 12.657.5 ± 11.288/4098/4423.03 ± 3.6123.66 ± 3.2321.826.751.50D2Jeong \[[@CR15]\]01/2005 12/2007RetrospectiveKorea26113769.312.813.64.3Kawamura \[[@CR16]\]01/2003 12/2008RetrospectiveJapan423063.6 ± 1064.9 ± 10.532/1021/922.7 ± 3.122.7 ± 2.9100000D2Kim \[[@CR17]\]01/2004 07/2006RetrospectiveKorea273357.3 ± 14.261.6 ± 9.216/1123/1022.6 ± 3.122.4 ± 2.1D1+ α/β/D2Kim \[[@CR18]\]01/2009 04/2010RetrospectiveKorea6312755.9 ± 12.257.3 ± 11.143/2081/4622.7 ± 2.523.0 ± 2.9D2Lin \[[@CR19]\]01/2005 10/2013RetrospectiveChina2041153961.0 ± 11.159.8 ± 10.81523/5181170/36922.3 ± 3.222.6 ± 3.526.619.953.60D1+ α/β/D2Mochiki \[[@CR20]\]04/1998 12/2007RetrospectiveJapan201866 ± 2.463 ± 2.216/416/292.12.65.30D1+ βSakuramoto \[[@CR21]\]07/2003 07/2007RetrospectiveJapan304463.7 ± 9.267.2 ± 9.912/1810/3421.9 ± 2.722.5 ± 3.65425.720.30D1+ β/D2Son \[[@CR22]\]05/2003 12/2009RetrospectiveKorea392250.7 ± 1452.4 ± 12.913/2610/12032.867.20D1+/D2Usui \[[@CR23]\]05/2011 08/2004RetrospectiveJapan201966.0 ± 10.466.2 ± 10.213/714/521.3 ± 3.122.1 ± 2.492.37.700

Operative results {#Sec10}
-----------------

Operation duration was shorter in the open group in both the Western studies and the Asian studies. The overall results of both subgroups showed a significant difference. Overall weighted mean difference was 30.84 min (95% CI, 8.12--64.81).

Blood loss was significantly less in the minimally invasive group. Overall weighted mean difference was −173.09 ml (95% CI, −216.74 to −129.43). Forest plots of operation duration and blood loss are depicted in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Operation duration and blood loss

Postoperative recovery {#Sec11}
----------------------

Hospital stay was significantly shorter in the minimally invasive group. Overall weighted mean difference was −3.46 days (95% CI, −4.49 to −1.63).

The time to first flatus showed a significant difference in favor of the minimally invasive group. In the analysis of only the Asian studies this was not significantly different; the overall weighted mean difference was −1.08 days (95% CI, −7.97 to −0.19).

Time to first diet showed a significant difference in favor of the minimally invasive group. Overall weighted mean difference was −1.85 days (95% CI, −3.61 to −0.10).

Forest plots of postoperative recovery are depicted in Fig. [2](#Fig2){ref-type="fig"}.Fig. 2Hospital stay, time to first flatus, and time to first diet

Morbidity and mortality {#Sec12}
-----------------------

Fewer complications occurred in the minimally invasive group in comparison to the open group. Analysis of only the Asian studies showed no significant difference between the two groups. However, overall the analysis showed a significant difference with an odds ratio (OR) of 0.73 (95% CI, 0.58--0.92).

No difference in mortality was seen between the two groups, with an odds ratio of 0.77 (95% CI, 0.49--1.23). Forest plots of morbidity and mortality are depicted in Fig. [3](#Fig3){ref-type="fig"}.Fig. 3Postoperative complications and mortality

Oncological outcomes {#Sec13}
--------------------

Significantly more lymph nodes were resected in the minimally invasive group in comparison to the open group, with an overall weighted mean difference of −1.41 lymph nodes (95% CI, −2.64 to −0.17). A forest plot of lymph node yield is depicted in Fig. [4](#Fig4){ref-type="fig"}.Fig. 4Lymph node yield

Four Asian studies reported radicality; all reported 100% R0 resections \[[@CR13]--[@CR15], [@CR22], [@CR24]\]. Seven Western studies reported radicality \[[@CR25]--[@CR30], [@CR32]\]. Only one had all R0 resections, all other studies also reported R1 resections; however there were no differences between the open or minimally invasive groups.

Seven Asian studies reported disease-free and/or overall survival \[[@CR13]--[@CR15], [@CR19]--[@CR22]\]. Three studies conducted in Western countries reported disease-free and/or overall survival \[[@CR26], [@CR29], [@CR31]\].

Follow-up duration differed between studies, making it difficult to compare these results. Only one study, that by Lin et al., reported a significant difference in survival between the two groups. In the overall 3-year disease free survival, a better survival rate was reported for the minimally invasive group. After comparing survival rates according to tumor stage, this difference disappeared.

Discussion {#Sec14}
==========

In conclusion, improved outcomes are observed following minimally invasive gastrectomy in comparison to open procedures in both Western and Asian studies.

There are differences in patient characteristics between the Western and Asian populations. Patient characteristics such as age and body mass index (BMI) are higher in the Western population, which may be explained by the fact that the incidence of gastric cancer is higher in Eastern Asia. Several Asian countries have a screening program for gastric cancer. In Japan, population-based screening is recommended for individuals older than 50 years and in Korea for individuals aged 40--75 years, resulting in a lower age of onset compared to the West \[[@CR7]\]. A higher BMI in the Western patient group could correspond to an overall higher BMI in the Western population. In the Netherlands more than 50% of the adult population has a BMI of 25 or higher, and approximately 36% had a BMI between 25 and 30 \[[@CR33]\]. Mean BMI in gastric cancer patients in 2014 was 25 \[[@CR34]\]. With more-advanced disease in gastric cancer in the West, an average normal BMI might reflect a cachectic overweight patient.

Both Western and Asian studies show better short-term outcomes in favor of minimally invasive surgical techniques, with faster postoperative recovery with a significant shorter hospital stay, shorter time to first flatus, and a shorter time to first diet. It should be noted that international implementation of enhanced recovery protocols (ERAS) might influence these results. Perioperative results show significantly less blood loss in the minimally invasive group; however, operation duration was longer. Additionally, fewer postoperative complications and no differences in mortality were reported. All these short-term advantages can be attributed to the less invasive nature of the minimally invasive approach. These outcomes are in accordance with other meta-analyses comparing minimally invasive with open gastrectomies \[[@CR9], [@CR10]\].

When comparing East with West, more blood loss and longer operation duration are seen in the Western studies, which may be attributed to the lower overall incidence of gastric cancer in Western countries. Blood loss and operation duration might not have clinical value, but these outcomes could indicate Western surgeons have less experience in the treatment of gastric cancer. Only one study reported on surgeon experience; one experienced surgeon performed all minimally invasive procedures \[[@CR32]\]. It should be noted that the incidence of performing minimally invasive gastrectomy was low in the Western studies. In all but one Western study fewer than 10 minimally invasive procedures were performed annually. With a learning curve reported at 20--40 procedures, this finding indicates progression through the learning curve is slow and might affect the presented results \[[@CR35]\].

With regard to complications and mortality, these outcomes seem to show a trend in favor of the Asian studies. There are two large studies reporting the outcomes of mortality rate \[[@CR19], [@CR27]\]. Analyses with and without these studies did not show an effect on the outcomes presented here. An overall significant difference in lymph node yield in the minimally invasive group was seen, with a mean difference of 1.41 lymph nodes. No effects on clinical outcome are to be expected from this result. More importantly, all studies reported an average of at least 19 resected lymph nodes, which is in accordance with the recommendations of the Japanese Gastric Cancer Association, which advocates removal of at least 15 lymph nodes \[[@CR1]\]. The overall differences in lymph node yield show a trend toward a higher number of resected lymph nodes in the Eastern studies, which can be attributed to the greater experience of Asian surgeons with the surgical treatment of gastric cancer. Additionally, pathological examination of lymph nodes can be different, with lymph node dissection taking place separately or en bloc. Furthermore, examination by a specialized upper gastrointestinal pathologist could influence the outcome. Unfortunately, no study reported if lymph node yield was done separately or en bloc.

The difference in survival reported by Lin et al. could be explained by the heterogeneity of both groups, with larger tumors and more advanced disease in the open group \[[@CR19]\].

Overall outcomes seem to be in favor of the Asian population. Future research should aim to further assess differences in population, patient assessment, surgical techniques, and experience, to ensure optimal treatment for all gastric cancer patients. In the West care for gastric cancer patients is more and more centralized to specialized treatment units, ensuring optimal care, not only by experienced surgeons, but by an experienced treatment team, ranging from preoperative workup to perioperative care and follow-up. The implementation of minimally invasive techniques for gastric cancer is progressing gradually in Western countries. Several randomized controlled trials are being conducted in the West comparing minimally invasive with open gastrectomy for gastric cancer \[[@CR36], [@CR37]\]. These developments may aid in diminishing the differences between the East and West.

Conclusion {#Sec15}
==========

Improved outcomes are observed in both Western and Asian studies following minimally invasive gastrectomy in comparison to open procedures. There are differences in patient characteristics between the Western and Asian population. Overall outcomes, such as lymph node yield, complications, and mortality, seem to be in favor of the Asian population. These differences may fade with centralization of care for gastric cancer patients in the West and increasing surgical experience.

Appendix {#Sec16}
========
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